Repositorio Dspace

Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial

Mostrar el registro sencillo del ítem

dc.contributor.author Sierra, Carlos
dc.contributor.author Blasco, Javier
dc.contributor.author Bernal, María-José
dc.contributor.author Martínez, Rosario
dc.contributor.author Ortuño, Inmaculada
dc.contributor.author Vasallo, María-Isabel
dc.contributor.author Vidal, María-Luisa
dc.contributor.author Dalmau, Jaime
dc.contributor.author Espin, Beatriz
dc.contributor.author Gil-Ortega, David
dc.contributor.author Infante, Damaso
dc.contributor.author Leis, Rosaura
dc.contributor.author Maldonado, José
dc.contributor.author Moreno, José-Manuel
dc.contributor.author Roman, Enriqueta
dc.date.accessioned 2026-10-20T11:26:59Z
dc.date.available 2026-10-20T11:26:59Z
dc.date.issued 2015-02
dc.identifier.citation Sierra C, Bernal MJ, Blasco J, Martínez R, Dalmau J, Ortuño I, et al. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. Eur J Nutr. febrero de 2015;54(1):89-99. doi:10.1007/s00394-014-0689-9
dc.identifier.issn 1436-6207
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28505
dc.description.abstract PURPOSE: Currently, there is no consensus concerning the possible beneficial colonic and systemic effects of prebiotic-containing infant formula. This study assesses whether the feeding of a galactooligosaccharides (GOS)-containing infant formula (0.44 g/dl of GOS) and the subsequent feeding of a GOS-containing follow-on formula (0.50 g/dl of GOS) have a prebiotic effect on intestinal microbiota that helps to decrease infections and allergy manifestations in healthy infants during the first year of life. METHODS: A multicentre, randomised, double-blind and placebo-controlled trial was carried out on 365 healthy term infants enrolled before 8 weeks of age and randomly assigned to a formula with or without GOS, until 12 months of age. The incidence of infections and allergy manifestations, the antibiotics prescribed and faecal characteristics were recorded up to 12 months of age, while faecal samples were collected up to 4 months for the measurement of secretory immunoglobulin A, short-chain fatty acids and microbiota. RESULTS: A prebiotic effect on the faecal analysis was observed at 4 months of life. The GOS group showed a lower faecal pH (P = 0.019), a lower decreasing trend in secretory immunoglobulin A (P = 0.078), lower butyric acid concentration (P = 0.040) and an increase in Bifidobacterium counts (P = 0.010). Changes in faecal characteristics involved greater frequency (P < 0.001) and softer consistency (P < 0.05). The incidence of infections or allergic manifestations during the first year of life was similar in both groups, with no statistical differences (P > 0.05). CONCLUSIONS: The feeding of GOS-containing infant formula produced a definite prebiotic effect consisting of changes in faecal composition and microbiota, and in faecal consistency and the frequency of defaecation. No changes in the incidence of infection or allergic manifestation during the first year of life were observed.
dc.language.iso eng
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Anti-Allergic Agents/therapeutic use
dc.subject.mesh Bifidobacterium/growth & development/isolation & purification/metabolism
dc.subject.mesh Cohort Studies
dc.subject.mesh Constipation/epidemiology/prevention & control
dc.subject.mesh Double-Blind Method
dc.subject.mesh Fatty Acids, Volatile/analysis/metabolism
dc.subject.mesh Feces/chemistry/microbiology
dc.subject.mesh Humans
dc.subject.mesh Hypersensitivity/epidemiology/prevention & control
dc.subject.mesh Immunity, Innate
dc.subject.mesh Immunoglobulin A, Secretory/analysis
dc.subject.mesh Immunologic Factors/therapeutic use
dc.subject.mesh Incidence
dc.subject.mesh Infant
dc.subject.mesh Infant Formula/chemistry
dc.subject.mesh Infections/epidemiology
dc.subject.mesh Lost to Follow-Up
dc.subject.mesh Male
dc.subject.mesh Oligosaccharides/therapeutic use
dc.subject.mesh Prebiotics
dc.subject.mesh Spain/epidemiology
dc.subject.mesh Trisaccharides/therapeutic use
dc.title Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 24671237
dc.relation.publisherversion http://link.springer.com/10.1007/s00394-014-0689-9
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1007/s00394-014-0689-9
dc.journal.title European Journal of Nutrition
dc.identifier.essn 1436-6215


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta